Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAX576 in controlled or partially controlled asthma
NCT00940160Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2009
- Primary completion
- Jan 2010
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of dectrekumab in asthma, sponsored by Novartis. Started Jul 2009; status: completed.
02
Drugs
dectrekumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00940160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00940160.